Literature DB >> 21527944

How to use biomarkers efficiently in acute kidney injury.

Norbert H Lameire1, Raymond C Vanholder, Wim A Van Biesen.   

Abstract

We discuss the performance of novel biomarkers in acute kidney injury (AKI). Comparison of the areas under the receiver operating characteristic curves of several biomarkers with some clinical and/or routine biochemical outcome parameters reveals that none of the biomarkers has demonstrated a clear additional value beyond the traditional approach in clinical decision making in patients with AKI. Unscrutinized use of these biomarkers may distract from adequate clinical evaluation and carries the risk of worse instead of better patient outcome.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21527944     DOI： 10.1038/ki.2011.21

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  27 in total

Review 1.  Subclinical AKI: ready for primetime in clinical practice?

Authors:  Jill Vanmassenhove; Wim Van Biesen; Raymond Vanholder; Norbert Lameire
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

2.  Tolerance of the human kidney to isolated controlled ischemia.

Authors:  Dipen J Parekh; Joel M Weinberg; Barbara Ercole; Kathleen C Torkko; William Hilton; Michael Bennett; Prasad Devarajan; Manjeri A Venkatachalam
Journal:  J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 10.121

3.  Neutrophil gelatinase-associated lipocalin does not predict acute kidney injury in heart failure.

Authors:  Fiorenza Ferrari; Elisa Scalzotto; Pasquale Esposito; Sara Samoni; Flavio Mistrorigo; Lilia Maria Rizo Topete; Massimo De Cal; Grazia Maria Virzì; Valentina Corradi; Rossella Torregrossa; Roberto Valle; Stefania Bianzina; Nadia Aspromonte; Matteo Floris; Alessandro Fontanelli; Alessandra Brendolan; Claudio Ronco
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

Review 4.  Update on biomarkers of acute kidney injury: moving closer to clinical impact?

Authors:  Helmut Schiffl; Susanne M Lang
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

Review 5.  Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective.

Authors:  Claudio Ronco; Matthieu Legrand; Stuart L Goldstein; Mina Hur; Nam Tran; Eric C Howell; Vincenzo Cantaluppi; Dinna N Cruz; Kevin Damman; Sean M Bagshaw; Salvatore Di Somma; Andrew Lewington
Journal:  Blood Purif       Date:  2014-07-03       Impact factor: 2.614

Review 6.  Acute kidney injury.

Authors:  John A Kellum; Paola Romagnani; Gloria Ashuntantang; Claudio Ronco; Alexander Zarbock; Hans-Joachim Anders
Journal:  Nat Rev Dis Primers       Date:  2021-07-15       Impact factor: 52.329

Review 7.  Cardiac surgery-associated acute kidney injury: pathophysiology and diagnostic modalities and management.

Authors:  Gontse Leballo; Palesa Motshabi Chakane
Journal:  Cardiovasc J Afr       Date:  2020-06-12       Impact factor: 1.167

Review 8.  Clinical review: Biomarkers of acute kidney injury: where are we now?

Authors:  Marlies Ostermann; Barbara J Philips; Lui G Forni
Journal:  Crit Care       Date:  2012-09-21       Impact factor: 9.097

9.  Erythropoietin in the intensive care unit: beyond treatment of anemia.

Authors:  Nimesh Sa Patel; Massimo Collino; Muhammad M Yaqoob; Christoph Thiemermann
Journal:  Ann Intensive Care       Date:  2011-09-23       Impact factor: 6.925

10.  A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy.

Authors:  Danilo Fliser; Maurice Laville; Adrian Covic; Denis Fouque; Raymond Vanholder; Laurent Juillard; Wim Van Biesen
Journal:  Nephrol Dial Transplant       Date:  2012-10-08       Impact factor: 5.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.